Without careful execution and the ability to navigate unexpected challenges, marketing application submissions are prone to falling off track and costing valuable time and resources
Explore Certara’s Simcyp Academic Awards and Grant Partnership Scheme, supporting innovative research in pharmacokinetics and pharmacodynamics.
Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This review provides a brief account of the current knowledge,...
Having the ability to scale with research needs is pivotal to success. Understanding when the time comes to automate processes can be challenging. This webinar will discuss data management practices small to mid-size biotech, and pharmaceutical companies should utilize to...
D360 partners with renowned organizations to provide comprehensive informatics systems for discovery research.
In this webinar, our experts provided an overview of the SNDS and the key working practices to access the database and ongoing SNDS developments, explained the similarities and differences between SNDS and other claims databases, used case studies to illustrate...
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US FDA’s accelerated approval programs, the company generated PBPK models using the Simcyp Simulator to inform dose, dosing regimens, and DDIs. Approved initially for mantle cell...
Simcyp® PBPK Modeling & Simulation software helps predict drug behavior, optimize dosing, and guide decisions for safer, more effective treatments.
© 2025 Certara. All Rights Reserved. | Legal | Privacy policy
